KARA ROCHE: Open Payments
NPI 1811433923 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,469 in 160 payments from 19 companies in 2025. Trend: 2023 $1,662 · 2024 $3,315 · 2025 $2,469
Food & beverage: $2,469
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 58 | $567 |
| ABBVIE INC. | 36 | $457 |
| GENZYME CORPORATION | 7 | $176 |
| Novartis Pharmaceuticals Corporation | 10 | $159 |
| Incyte Corporation | 6 | $147 |
| UCB, Inc. | 4 | $142 |
| PFIZER INC. | 7 | $122 |
| Journey Medical Corporation | 1 | $121 |
| Organon LLC | 10 | $114 |
| Galderma Laboratories, L.P. | 4 | $84 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, OPZELURA, RINVOQ, Bimzelx, COSENTYX, CIBINQO.
Industry payments across OH — which companies pay providers there.
